The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients
1 other identifier
observational
307
1 country
1
Brief Summary
Inflammatory Bowel Diseases (IBD) are life-long, incurable illnesses that can have a profound effect on the patients quality of life. Disease education is a corner stone of IBD care to enable patients to take up an active role in their disease management. While patient education is enshrined in the IBD standards, actual patient knowledge is often poor.3 Knowledge is not associated with the level of the patient's educational achievement, but member of patient organisations such as Crohn's and Colitis UK (CCUK) have significantly better knowledge than non-members. This may highlight the positive effects of education offered by CCUK, but it is also conceivable that patients with a greater interest in their disease are more like to join organisations like CCUK. Different sources of patient information may therefore influence what level of disease related knowledge a patient achieves. Apart from high quality clinical information provided by professional organisation (British Society of Gastroenterology, European Crohn's and Colitis Organisation), the National Health Service and charities (CORE, CCUK), there is also a host of unregulated information available. The emerging dominance of the internet for information gathering has provided easy access for patients to a host of websites providing information on IBD. A number of these provide alternative (not evidence based) views, which could have a potentially negative impact on patient's knowledge. Furthermore patients often share their stories on internet forums and it is likely that those stories share are more likely to represent the extreme ends of disease rather than those experienced by the majority. This could potentially cause anxiety in patients with IBD. The quality of information found on the internet varies widely and up to 50% of websites have been judged as poor. The vast majority of patients with IBD have access to the internet and more than half use to search for health related information.7 We have previously also demonstrated that patients with anxiety have better disease related knowledge of IBD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2013
CompletedFirst Posted
Study publicly available on registry
August 5, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedMarch 22, 2016
March 1, 2016
2.3 years
July 31, 2013
March 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CCKNOW
CCKNOW scores according to preferred information source
12 months
Secondary Outcomes (1)
HADS-A
12 months
Study Arms (1)
IBD patients
Ambulatory patients attending IBD clinics at Leeds Teaching Hospitals
Interventions
Eligibility Criteria
ambulatory patients attending IBD clinics at Leeds Teaching Hospitals
You may qualify if:
- patients attending IBD clinics at Leeds Teaching Hospitals
You may not qualify if:
- Individuals who are unable to give informed consent.
- Individuals who do not speak English, as the questionanire is selfadministered.
- Individuals under 18 years of age.
- Individuals who are attending Gastroenterology clinics at Leeds General Infirmary and St. James's University Hospital because of a flare up of disease activity of their ulcerative colitis or Crohn's disease.
- Individuals with Crohn's disease who have a stoma (ileostomy), due to practical difficulties in assessing clinical activity in this patient group (it is not actually possible to calculate the HarveyBradshaw index in patients with an ileostomy).
- Individuals who, in the opinion of the investigator, are not suitable to participate in the study.
- Individuals who refuse to give written, informed consent to be involved.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leeds Teaching Hospitals NHS Trust
Leeds, Yorkshire, LS9 7TF, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Gastroenterologist
Study Record Dates
First Submitted
July 31, 2013
First Posted
August 5, 2013
Study Start
October 1, 2013
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
March 22, 2016
Record last verified: 2016-03